Mineralocorticoid/NN
effector/NN
mechanism/NN
in/IN
preeclampsia/NN
./.

Mineralocorticoid/NN
effector/NN
mechanisms/NNS
were/VBD
evaluated/VBN
in/IN
29/CD
patients/NNS
with/IN
preeclampsia/NN
and/CC
in/IN
25/CD
uncomplicated/JJ
pregnancies/NNS
by/IN
measurement/NN
of/IN
plasma/NN
aldosterone/NN
,/,
levels/NNS
of/IN
mineralocorticoid/NN
receptor/NN
(/(
MR/NN
)/)
in/IN
mononuclear/JJ
leucocytes/NNS
,/,
and/CC
subtraction/NN
potential/NN
difference/NN
(/(
SPD/NN
;/:
rectal/JJ
minus/CC
oral/JJ
values/NNS
)/)
./.
=====
Mean/NN
values/NNS
for/IN
plasma/NN
aldosterone/NN
were/VBD
not/RB
different/JJ
between/IN
the/DT
two/CD
groups/NNS
,/,
but/CC
significant/JJ
differences/NNS
were/VBD
observed/VBN
for/IN
MR/NN
(/(
preeclampsia/NN
,/,
81/CD
+/-/CC
44/CD
receptors/cell/NNS
;/:
controls/NNS
,/,
306/CD
+/-/CC
168/CD
)/)
and/CC
SPD/NN
(/(
preeclampsia/NN
,/,
65/CD
+/-/CC
7/CD
mV/NN
;/:
controls/NNS
,/,
12/CD
+/-/CC
5/CD
mV/NN
)/)
./.
=====
In/IN
six/CD
cases/NNS
we/PRP
determined/VBD
MR/NN
,/,
plasma/NN
aldosterone/NN
,/,
and/CC
SPD/NN
in/IN
patients/NNS
with/IN
preeclampsia/NN
before/IN
and/CC
3/CD
months/NNS
after/IN
delivery/NN
./.
=====
MR/NNS
were/VBD
reduced/VBN
before/IN
delivery/NN
(/(
96/CD
+/-/CC
27/CD
receptors/cell/NNS
)/)
,/,
and/CC
SPD/NN
increased/VBD
(/(
64/CD
+/-/CC
8/CD
mV/NN
)/)
,/,
with/IN
both/DT
parameters/NNS
normalizing/VBG
after/IN
delivery/NN
(/(
MR/NN
,/,
242/CD
+/-/CC
79/CD
;/:
SPD/NN
,/,
14.0/CD
+/-/CC
4/CD
mV/NN
)/)
./.
=====
Aldosterone/NN
levels/NNS
returned/VBD
to/TO
normal/JJ
nonpregnant/JJ
values/NNS
after/IN
delivery/NN
./.
=====
These/DT
data/NNS
suggest/VBP
an/DT
important/JJ
role/NN
for/IN
abnormalities/NNS
in/IN
mineralocorticoid/NN
effector/NN
mechanisms/NNS
in/IN
the/DT
etiology/NN
of/IN
preeclampsia/NN
and/CC
could/MD
be/VB
an/DT
useful/JJ
marker/NN
for/IN
diagnosis/NN
./.